Source: Pediatric Blood and Cancer. Conference titles: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: MEDULOBLASTOMA, ANTINEOPLÁSICOS
ABNT
GERON, L. et al. Antitumor activity of AMG900 alone or in combination with histone deacetylase inhibitor SaHa on medulloblastoma cell lines. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 29 set. 2024. , 2014APA
Geron, L., Suazo, V. K., Andrade, A. F., Borges, K. S., Scrideli, C. A., & Tone, L. G. (2014). Antitumor activity of AMG900 alone or in combination with histone deacetylase inhibitor SaHa on medulloblastoma cell lines. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Geron L, Suazo VK, Andrade AF, Borges KS, Scrideli CA, Tone LG. Antitumor activity of AMG900 alone or in combination with histone deacetylase inhibitor SaHa on medulloblastoma cell lines. Pediatric Blood and Cancer. 2014 ; 61 S280.[citado 2024 set. 29 ]Vancouver
Geron L, Suazo VK, Andrade AF, Borges KS, Scrideli CA, Tone LG. Antitumor activity of AMG900 alone or in combination with histone deacetylase inhibitor SaHa on medulloblastoma cell lines. Pediatric Blood and Cancer. 2014 ; 61 S280.[citado 2024 set. 29 ]